Edward Korot1, Grant Comer2, Timothy Steffens2, David A Antonetti2. 1. Beaumont Eye Institute, Royal Oak, Michigan2Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor. 2. Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor.
Abstract
IMPORTANCE: Developing a noninvasive measure of diabetic retinopathy disease progression may provide physicians with information needed for patient-specific intervention. OBJECTIVE: To develop an algorithm to measure vitreous hyperreflective foci (VHRF) from standard, 3-dimensional optical coherence tomographic (OCT) images in an unbiased manner. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively analyzed OCT scans from 97 patients who were evaluated at the Kellogg Eye Center, University of Michigan. Patients with diabetes mellitus without signs of retinopathy (n = 9) and patients with diabetic macular edema (DME) (n = 31) were compared with healthy control participants (n = 37). The algorithm was used to determine whether the VHRF score is associated with DME and may serve as a noninvasive measure of inflammation. The study was conducted from November 14, 2011, to August 5, 2015. Data analysis was performed from May 15, 2014, to August 13, 2015. MAIN OUTCOMES AND MEASURES: An algorithm was developed to enhance the vitreous imaging from OCT to allow automated quantification of VHRF and calculation of a VHRF score. This score was compared between the healthy control, diabetes without retinopathy, and DME groups. RESULTS: In the 97 scans evaluated, VHRF scores, reported as mean (SD), were increased in patients with DME by 2.95-fold (5.60 [8.65]) compared with healthy controls (1.90 [3.42]; 95% CI, 0.75-7.45; P = .012) and by 6.83-fold compared with patients with diabetes without retinopathy (0.82 [1.26]; 95% CI, 1.46-8.82; P = .005). CONCLUSIONS AND RELEVANCE: Scores obtained using the VHRF algorithm may be obtained from OCT images that include the vitreous and could provide a rapid, noninvasive clinical correlate for ocular inflammation. Higher VHRF scores in patients with DME compared with controls and diabetic patients without retinopathy warrant further population-based and longitudinal studies to help determine the value of the VHRF score in selecting therapeutic intervention.
IMPORTANCE: Developing a noninvasive measure of diabetic retinopathy disease progression may provide physicians with information needed for patient-specific intervention. OBJECTIVE: To develop an algorithm to measure vitreous hyperreflective foci (VHRF) from standard, 3-dimensional optical coherence tomographic (OCT) images in an unbiased manner. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively analyzed OCT scans from 97 patients who were evaluated at the Kellogg Eye Center, University of Michigan. Patients with diabetes mellitus without signs of retinopathy (n = 9) and patients with diabetic macular edema (DME) (n = 31) were compared with healthy control participants (n = 37). The algorithm was used to determine whether the VHRF score is associated with DME and may serve as a noninvasive measure of inflammation. The study was conducted from November 14, 2011, to August 5, 2015. Data analysis was performed from May 15, 2014, to August 13, 2015. MAIN OUTCOMES AND MEASURES: An algorithm was developed to enhance the vitreous imaging from OCT to allow automated quantification of VHRF and calculation of a VHRF score. This score was compared between the healthy control, diabetes without retinopathy, and DME groups. RESULTS: In the 97 scans evaluated, VHRF scores, reported as mean (SD), were increased in patients with DME by 2.95-fold (5.60 [8.65]) compared with healthy controls (1.90 [3.42]; 95% CI, 0.75-7.45; P = .012) and by 6.83-fold compared with patients with diabetes without retinopathy (0.82 [1.26]; 95% CI, 1.46-8.82; P = .005). CONCLUSIONS AND RELEVANCE: Scores obtained using the VHRF algorithm may be obtained from OCT images that include the vitreous and could provide a rapid, noninvasive clinical correlate for ocular inflammation. Higher VHRF scores in patients with DME compared with controls and diabeticpatients without retinopathy warrant further population-based and longitudinal studies to help determine the value of the VHRF score in selecting therapeutic intervention.
Authors: Pearse A Keane; Michael Karampelas; Dawn A Sim; Srinivas R Sadda; Adnan Tufail; H Nida Sen; Robert B Nussenblatt; Andrew D Dick; Richard W Lee; Philip I Murray; Carlos E Pavesio; Alastair K Denniston Journal: Ophthalmology Date: 2014-05-15 Impact factor: 12.079
Authors: John L Ubels; Cheng-Mao Lin; David A Antonetti; Monica Diaz-Coranguez; Cassandra R Diegel; Bart O Williams Journal: Exp Eye Res Date: 2022-02-06 Impact factor: 3.770
Authors: Cheng-Mao Lin; Paul M Titchenell; Jason M Keil; Adolfo Garcia-Ocaña; Mark T Bolinger; Steven F Abcouwer; David A Antonetti Journal: Am J Pathol Date: 2018-09-13 Impact factor: 4.307
Authors: Odunayo O Mugisho; Ilva D Rupenthal; David M Squirrell; Sarah J Bould; Helen V Danesh-Meyer; Jie Zhang; Colin R Green; Monica L Acosta Journal: PLoS One Date: 2018-08-22 Impact factor: 3.240